MEDIFAST INC
Data quality: 100%
MED
NYSE
Manufacturing
Food Products
$10.21
▼
$0.02
(-0.15%)
Mkt Cap: 112.58 M
Price
$10.21
Mkt Cap
112.58 M
Day Range
$10.10 — $10.26
52-Week Range
$9.22 — $15.46
Volume
175,513
Open $10.12
50D / 200D Avg
$10.59
3.62% below
50D / 200D Avg
$12.29
16.96% below
Quick Summary
Key Takeaways
Earnings declined -992.97% over the past year
Generating 1.25 M in free cash flow
Capital efficient — spends only 1.46% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-35.96%
Earnings (1Y)-992.97%
FCF Growth (3Y)-90.59%
Quality
Return on Equity
-8.67%
Above sector avg (-51.02%)
ROIC-5.05%
Net Margin-4.84%
Op. Margin-3.68%
Safety
Debt / Equity
N/A
Current Ratio4.45
Interest CoverageN/A
Valuation
PE (TTM)
-6.03
Below sector avg (-1.98)
P/B Ratio0.52
EV/EBITDA450.08
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.0 | -2.0 |
| P/B | 0.5 | 5.1 |
| ROE % | -8.7 | -51.0 |
| Net Margin % | -4.8 | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
ETFs Holding This Stock
0.34% weight
0.27% weight
0.14% weight
0.03% weight
0.03% weight
0.03% weight
0.02% weight
0.02% weight
0.00% weight
0.00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -35.96% | Revenue Growth (3Y) | -40.01% |
| Earnings Growth (1Y) | -992.97% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 385.79 M | Net Income (TTM) | -18.67 M |
| ROE | -8.67% | ROA | -6.95% |
| Gross Margin | 71.33% | Operating Margin | -3.68% |
| Net Margin | -4.84% | Free Cash Flow (TTM) | 1.25 M |
| ROIC | -5.05% | FCF Growth (3Y) | -90.59% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.45 |
| Interest Coverage | N/A | Asset Turnover | 1.44 |
| Working Capital | 161.13 M | Tangible Book Value | 214.71 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6.03 | Forward P/E | N/A |
| P/B Ratio | 0.52 | P/S Ratio | 0.29 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 450.08 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1.11% | ||
| Market Cap | 112.58 M | Enterprise Value | 13.05 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.70 | Revenue / Share | 34.97 |
| FCF / Share | 0.11 | OCF / Share | 0.62 |
| EPS CAGR (1Y) | -994.74% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1.46% | FCF Conversion | -6.69% |
| SBC-Adj. FCF | -4.82 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 385.79 M | 602.46 M | 1.07 B | — | — |
| Net Income | -18.67 M | 2.09 M | 99.42 M | 143.57 M | 164.03 M |
| EPS (Diluted) | -1.70 | 0.19 | 9.10 | 12.73 | 13.89 |
| Gross Profit | 275.19 M | 444.62 M | 775.85 M | 1.14 B | 1.13 B |
| Operating Income | -14.21 M | 2.88 M | 126.40 M | 184.81 M | 216.24 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 4.30 M | 4.60 M | 4.60 M | 4.50 M | 4.40 M |
| SG&A Expenses | 289.40 M | 441.75 M | 649.45 M | 955.61 M | 911.36 M |
| D&A | 14.24 M | 12.71 M | 13.11 M | 10.98 M | 6.81 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 13.03 M | 1.70 M | 29.38 M | 40.49 M | 52.10 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 247.97 M | 284.21 M | 309.91 M | 316.21 M | 398.33 M |
| Total Liabilities | 49.05 M | 74.10 M | 108.43 M | 161.17 M | 195.85 M |
| Shareholders' Equity | 198.92 M | 210.11 M | 201.48 M | 155.04 M | 202.47 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 89.30 M | 90.93 M | 94.44 M | 87.69 M | 104.18 M |
| Current Assets | 201.68 M | 214.40 M | 224.03 M | 222.78 M | 306.87 M |
| Current Liabilities | 42.96 M | 64.16 M | 92.30 M | 140.89 M | 169.83 M |
{"event":"ticker_viewed","properties":{"ticker":"MED","listing_kind":"stock","pathname":"/stocks/med","exchange":"NYSE","country":"US"}}









